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Miri, in the north of Sarawak in 2007. Stool samples collected
from these two isolated outbreaks were tested for rotavirus,
which is a primary etiological agent of gastroenteritis. This
study aimed to characterize the G (VP7) and P (VP4) geno-
types of group A human rotavirus circulating in these two
outbreaks. The G and P types of the rotavirus-positive faecal
specimens were determined by reverse-transcription PCR
and sequencing.
Methods: Faecal specimens were resuspended in PBS
and were subjected to nucleic acid extraction by using
the Chemagic Viral Extraction Kit (Chemagen, Germany).
Rotavirus was detected by RT-PCR using published primers
speciﬁc for VP4 and VP7. Positive samples were subjected
to DNA sequencing and partial sequences of the G and P gene
were analysed using Lasergene (DNASTAR, Madison WI, USA)
software and phylogenetic tree analysis using a neighbour-
joining method.
Results: A total of 272 samples were tested for rotavirus
and of these 75 (72%) and 68 (40%) in Serian and Miri respec-
tively, were positive for group A human rotavirus. A total of
105 sequences were obtained, and ﬁve different G-P combi-
nations were identiﬁed. In both outbreaks, G1[P8] were the
most common strains found which constituted of 87.6% of all
the rotavirus typed. Other genotypes include the emergent
strains G9[P8] (7.6%), G2[P4] (3.8%) and a rare G3[P9] (1%).
Out of the 5 combinations only G1[P8] and G9[P8] strains
were identiﬁed in the 2001 outbreak in Serian while G1[P8],
G2[P4] and G3[P9] were found circulating in the 2007 out-
break in Miri.
Conclusion: Given variations observed in circulating
rotavirus strains, continued monitoring of genotypes is
essential to identify emerging strains, track common strains
and evaluate impact of rotavirus vaccines.
doi:10.1016/j.ijid.2008.05.229
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Background: Human enteroviruses are the leading cause
of aseptic meningitis (ASM) worldwide. Human echovirus 30
(E30), together with E9 and E11, are the enteroviruses most
frequently implicated in community outbreaks of ASM. In
Sarawak, in 2001 and 2004, we have isolated E30 from a
number of patients during a prospective study of central
nervous system infection.
Methods: The complete nucleotide sequences of the VP1
gene for 23 E30 isolates from Sarawak were determined
by RT-PCR and sequencing using published and in-house
designed primer sets. The relationship between the 23
Sarawakian E30 VP1 sequences and an additional 470 E30 VP1
sequences obtained from the GenBank database were inves-
tigated by phylogenetic analysis using a maximum likelihood
approach.
Results: The phylogenetic analysis of all 493 E30 VP1
sequences revealed 3 separate genotype groups which
included two previously published genotypes (I and II) and
a previously undescribed genotype that we have desig-
nated as genotype III. The Sarawak strains belonged to
two separate genotypes (II and III). Strains isolated in 2001
belonged to genotype II whereas strains isolated in 2004
were from genotypes II and III. A global comparison of E30
VP1 sequences revealed that multiple lineages (within or
in separate genotype groups) of E30 strains may circulate
at any one time. This is in contrast to previously published
reports that a single virus lineage appear to circulate at a
time and that temporal displacement of the lineage occurs
with time. Our results also showed that E30 strains can be
divided geographically into ‘continental’ and ‘cosmopolitan’
types.
Conclusions: Increased capacity for virus diagnostics has
improved our appreciation for the disease burden of E30.
This has led to the description of an emerging genotype (III)
and a better understanding of the molecular epidemiology
of E30.
doi:10.1016/j.ijid.2008.05.230
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Backgrounds and Purpose: In Taiwan, hepatitis B virus
(HBV) infection is the leading cause of acute viral hepati-
tis. An effective universal HBV vaccination program was
launched since 1984. We assessed the impact of vaccination
on acute hepatitis B in terms of incidence and risk factors.
Methods: Cases deﬁnition of acute hepatitis B meets the
clinical and laboratory criteria. HBsAg existed less than 6
months and IgM-anti-HBc positive are necessary. From 1994
to 2007, reported cases to Taiwan CDC via the National
Notiﬁable Diseases Surveillance System were enrolled. The
incidence of birth cohorts who were born between 1974 and
1993 (10 years after or before vaccine introduction) was
further analyzed. Risk factors were recorded.
Results: Totally, 4255 patients (gender: 1326F/2929M;
birth years: 1902—2007) were diagnosed as acute hepatitis
B, representing 52% of all acute viral hepatitis patients in 14
years. The median age of onset was 31 years (range, 0—94
years), and the overall incidence was 1.43/100,000 (range,
1.01—1.88/100,000). For people’s birth years between 1974
and 1983 (n = 1388), the incidence of acute hepatitis B was
34.59/100,000 (range, 9.65—44.46/100,000). It decreased
to 4.06/100,000 (range, 0.62—12.13/100,000) for those
birth years between 1984 and 1993 (n = 131) and their HBV
vaccine coverage was 86.19% (range, 75.70—92.05%). Possi-
ble risk factors were investigated for cases reported during
2006 and 2007. The occurrence of acute hepatitis B may be
related to people who had recent surgery (22.9%), lived with
family members of HBV carries (12.5%), or had HCV infection
(7.6%). Sharing razors or toothbrushes (6.9%), acupuncture
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(6.3%), and body piercing or body tattoo etc. (5.6%) are the
possible ways of transmission.
Conclusion: Reported acute hepatitis B incidence has
declined by 88.3% between people whose birth years were
during 1974—1983 and 1984—1993 (p < 0.001). The universal
Hepatitis B immunization program did protect people from
HBV infection.
doi:10.1016/j.ijid.2008.05.231
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Background: Since 1998, the serology for HTLV-1/2
became mandatory in blood centers from Peru. Although
several epidemiological studies conducted in Peru disclosed
HTLV-1 as the prevalent in different ethnic groups, HTLV-2
has been detected in Indians from Amazonian and in males
that have sex with males. Up to now, no data concerning
HTLV-1/2 infection in blood donors from Arequipa, a high-
lands region in the South of Peru is available. Thus, the
present study aimed to search for the presence of HTLV-1/2
antibodies in blood donors from this geographic area.
Methods: In 2005, 2,732 blood donors from Hospital
Goyeneche and Hospital Honorio Delgado Espinoza had their
blood screened for the presence of HTLV-1/2-speciﬁc anti-
bodies using enzyme immunosorbent assay (ELISA). The
reactive serum samples had their blood bags discarded from
donation, and the sera were sent to Instituto Adolfo Lutz
of Sa˜o Paulo, Brazil, to conﬁrm and discriminate HTLV-1
from HTLV-2 using ELISA and Western Blot (WB) tests. HTLV
positive sera were analyzed according to demographic char-
acteristics of individuals.
Results: Thirty-ﬁve serum samples (1.2%) resulted
HTLV-seroreactive on ELISA, and 25 conﬁrmed HTLV-1-
seropositivity by WB. One serum disclosed HTLV-positivity,
and the remained 9 samples resultedWB-seroindeterminate:
three with an HTLV-1 Gag indeterminate proﬁle. The median
age of HTLV-positive individuals was 34.6 years; 27 were
male and 8 female. All individuals were from the South
region of Peru; 27 from Arequipa, 5 from Puno, and 3 from
Cuzco. HTLV co-positivity with HBc was detected in four
sera, HBsAg in one serum and RPR in another serum. Pre-
vious transfusion and tattoo were described in two and one
individual, respectively.
Conclusions: This study conﬁrmed for the ﬁrst time
HTLV-1 infection and the lack of HTLV-2 infection in blood
donors from the South of Peru. The absence of sexual and
other retroviral risk factors in such individuals suggests that
vertical transmission could be the major route of HTLV-1
transmission/acquisition in this geographic region.
Support: CNPq, Brazil.
doi:10.1016/j.ijid.2008.05.232
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Introduction: There is a risk infection with HBV, HCV,
HIV, HTLV-I in personels of cardiac catheterization labora-
tories. The aim of this study was to determine the exact
need for asking laboratory tests for patients admitted for
cardiac catheterization.
Methods: Currently, the ELISA immonologic tests are
asked for all patients admitted for catheterization in Iran.
In this simple cross - sectional expriment, we studied the
results from ELISA tests in patients admitted for cardiac
catheterization in Imam Reza hospital from March 19, 2002
to July 19, 2005. After data collection, they were analyzed
with SPSS software.
Results: From all 8122 patients, 417 (5.1%) cases had
infection. We didn’t detect any HIV+ case. Most of infec-
tions were HTLV-1+ (2.59%), then HBV+ (2.37%) and HCV+
(0.3%). Most of cases were from Mashhad, Neishaboor and
Sabzevar.
Conclusion: This study shows that the frequency of infec-
tions specially with HIV is rare, and their risk of transmission
is low. We can sterilize our instruments and use desinfec-
tants to decrease the risk of infection and there are false
positive and false negative results in laboratory tests. Also,
there is effective vaccine against the most common agent of
infection, i.e HBV and we can vaccinate all the personal. So
asking for these laboratory tests is not indicated. Universal
precautions, is recommended instead of asking laboratory
tests and decrease costs for patients.
doi:10.1016/j.ijid.2008.05.233
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Background: Since 1981, there were several outbreaks
reported in Taiwan, especially southern Taiwan, an endemic
area for dengue fever. We conducted this study to clarify the
characteristics of this febrile disease.
Methods: Seventy-six serologically (ELISA and/or RT-PCR)
conﬁrmed cases of dengue fever between July 2006 and
